|
Canada-0-PATIO Azienda Directories
|
Azienda News:
- Encoded Therapeutics – Translating Next-Generation Science into . . .
Translating Next-Generation Science Into Transformative Gene Therapies Learn About Our Programs
- Programs – Encoded Therapeutics
Encoded is building an internally developed pipeline of best- and potentially first-in-class therapies focused on pediatric central nervous system (CNS) disorders
- About – Encoded Therapeutics
In addition to Encoded Therapeutics, Bryan is currently involved with companies across therapeutics, genomics, and health tech, including Aledade, Devoted Health, Element Biosciences, Included Health, Interdict, Kelonia Therapeutics, Lyra Health, Moonlight Bio, Mythic Therapeutics, SmithRx and Suki ai
- Encoded Therapeutics Announces U. S. FDA Breakthrough Therapy . . .
Encoded Therapeutics Announces U S FDA Breakthrough Therapy Designation Granted to ETX101 for the Treatment of Dravet Syndrome – Designation recognizes the potential of ETX101 to address a serious condition with high unmet need – SOUTH SAN FRANCISCO, Calif — January 12, 2026 — Encoded Therapeutics, Inc (“Encoded”), a clinical-stage biotechnology company developing precision
- Encoded Therapeutics Presents Positive Interim Efficacy Data from . . .
Encoded Therapeutics Presents Positive Interim Efficacy Data from Initial Dose Levels of Phase 1 2 Trials Evaluating ETX101 Gene Therapy in Dravet Syndrome – Median seizure reduction of 78% through seven months of observation at the third dose level – – Clinically meaningful gains in multiple measures of neurodevelopment across initial three dose levels, including substantial
- News – Encoded Therapeutics
News Events Press Releases March 25, 2026 Encoded Therapeutics Announces FDA Alignment, Initiation of Pivotal Study, and ASGCT Presidential Symposium Presentation of ETX101 in Dravet Syndrome January 12, 2026 Encoded Therapeutics Announces U S FDA Breakthrough Therapy Designation Granted to ETX101 for the Treatment of Dravet Syndrome January
- Clinical Studies – Encoded Therapeutics
Data from observational studies and clinical trials, which depend on volunteer participants, form the foundation of regulatory authorities’ decisions to approve new therapies for broader use
- Our Science – Encoded Therapeutics
Our Science The precision gene therapies being developed at Encoded are designed to modulate gene expression within specific cell types to potentially address the underlying disease mechanism
- Careers – Encoded Therapeutics
Encoded team members are creative, passionate and collaborative We invite you to join us in our mission to develop transformative therapies by fostering a culture of relentless patient focus, creativity and scientific exploration
|
|